$ITGR

Integer Holdings shares fell 28% as insider sold $70k in stock amid concerns over elevated 3.0x leverage and margin sustainability despite 8% revenue growth to $1.85B.

Law firm investigates securities fraud claims against ASP Isotopes, Integer Holdings, Molina Healthcare, and Soleno Therapeutics for alleged misstatements regarding technology, competitive position, medical costs, and drug safety.

Four public companies face securities fraud investigations alleging misrepresentation of core operations, product safety, and regulatory compliance.

Integer Holdings appoints independent directors James Flanagan and Aaron Kapito to board, signaling renewed growth focus with organic sales expected to return to market levels in 2026 and exceed them in 2027.

Grabar Law Office investigates shareholder claims against $CORT, $ITGR, $KD, and $MOH for alleged disclosure failures and fiduciary breaches spanning clinical trials, sales concealment, and cost trend non-disclosure.

Integer Holdings to present at three major healthcare investment conferences in March 2026, including Raymond James, Oppenheimer, and KeyBanc events.

Surgery Partners shares fell 39.7% as major fund exits position amid high debt concerns, despite 6.6% revenue growth. Elevated leverage weighs on investor confidence.

Irenic Capital divests 70% of Papa John's stake due to underperformance, with stock down 30.7% over past year amid broader QSR sector challenges.

Integer Holdings stock rose 2% after Q4 earnings beat expectations and analyst upgrades. Multiple firms raised price targets, citing strong sales growth and improved profit margins.